Qu Ling-Hui, Jin Xin, Xu Hai-Wei, Li Shi-Ying, Yin Zheng-Qin
Southwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, 400038, China.
Mol Genet Genomics. 2015 Feb;290(1):353-63. doi: 10.1007/s00438-014-0915-4. Epub 2014 Sep 25.
Usher syndrome (USH) is the most common cause of combined blindness and deafness inherited in an autosomal recessive mode. Molecular diagnosis is of great significance in revealing the molecular pathogenesis and aiding the clinical diagnosis of this disease. However, molecular diagnosis remains a challenge due to high phenotypic and genetic heterogeneity in USH. This study explored an approach for detecting disease-causing genetic mutations in candidate genes in five index cases from unrelated USH families based on targeted next-generation sequencing (NGS) technology. Through systematic data analysis using an established bioinformatics pipeline and segregation analysis, 10 pathogenic mutations in the USH disease genes were identified in the five USH families. Six of these mutations were novel: c.4398G > A and EX38-49del in MYO7A, c.988_989delAT in USH1C, c.15104_15105delCA and c.6875_6876insG in USH2A. All novel variations segregated with the disease phenotypes in their respective families and were absent from ethnically matched control individuals. This study expanded the mutation spectrum of USH and revealed the genotype-phenotype relationships of the novel USH mutations in Chinese patients. Moreover, this study proved that targeted NGS is an accurate and effective method for detecting genetic mutations related to USH. The identification of pathogenic mutations is of great significance for elucidating the underlying pathophysiology of USH.
乌谢尔综合征(USH)是常染色体隐性遗传的致盲和致聋合并症的最常见病因。分子诊断对于揭示该疾病的分子发病机制及辅助临床诊断具有重要意义。然而,由于USH存在高度的表型和基因异质性,分子诊断仍然是一项挑战。本研究基于靶向二代测序(NGS)技术,探索了一种检测来自无关USH家系的5例先证者候选基因中致病基因突变的方法。通过使用既定的生物信息学流程进行系统数据分析和家系遗传分析,在这5个USH家系中鉴定出10个USH疾病基因的致病突变。其中6个突变为新发现的突变:MYO7A基因中的c.4398G>A和EX38 - 49del、USH1C基因中的c.988_989delAT、USH2A基因中的c.15104_15105delCA和c.6875_6876insG。所有新发现的变异在各自家系中均与疾病表型共分离,且在种族匹配的对照个体中未出现。本研究扩展了USH的突变谱,揭示了中国患者中新发现的USH突变的基因型 - 表型关系。此外,本研究证明靶向NGS是检测与USH相关基因突变的准确有效方法。致病突变的鉴定对于阐明USH潜在的病理生理学具有重要意义。